Clinical Performance of ARS Containing Universal Adhesives in Carious Cervical Lesions

August 30, 2024 updated by: Ahmed El-Kotaby, Cairo University

Clinical Performance of Universal Adhesive with and Without Acid Resistant Silane Coupling Agent in Carious Cervical Lesions :A Randomized Controlled Trial

Evaluation of composite restorations done in carious cervical lesions restored by a conventional universal adhesive in comparison to a universal adhesive that contains and resistant silane coupling agent according to the Modified United States Public Health Service (USPHS) criteria over 18 months.

Study Overview

Detailed Description

The presence of acidic monomers in the bottle during storage can lead to the hydrolysis of silane contained in universal adhesives, potentially reducing its effectiveness and causing instability,The acid resistant silane coupling agent has a protective structure against attacks from acidic monomers. Therefore, long-term storage stability can be expected by suppressing hydrolysis. The protective structure is removed when the concentration of acidic monomers increases by air drying after application. This activates ARS, exerting the silane coupling effect.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Cairo, Egypt
        • Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants Inclusion:

    • Adults aging from 21-67 years old who were in need of restoration of at least one notch-shaped cervical lesion

  • Teeth Inclusion:

    • Vital teeth with carious cervical lesions in incisors , canines ,premolars& molars

Exclusion Criteria:

  • Participants Exclusion:

    • Patients with fewer than 20 teeth
    • Poor oral hygiene
    • Uncontrolled periodontal disease
    • Xerostomia
    • Known allergy to resin-based materials
    • Medically compromised, pregnant, or breast-feeding
  • Teeth Exclusion:

    • Non vital teeth
    • Teeth that are out of occlusion
    • Previously restored teeth

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Universal adhesive without acid resistant silane coupling agent
Universal adhesive with normal silane (comparator) After the acid etching and rinsing and drying step, the universal adhesive with normal silane will be actively applied for 20 second , then light cured for 20 seconds then the restoration will be placed
After cavity preparations, enamel margins will be etched for 30 seconds then rinsed and dried, then the Universal adhesive without acid resistant silane coupling agent will be actively applied for 20 seconds then air thinned for 5 seconds then cured for 20 seconds.Then the composite restoration will be placed.
Experimental: Universal adhesive with acid resistant silane coupling agent
Universal adhesive with acid resistant silane coupling agent (Intervention) After the acid etching and rinsing and drying step, the universal adhesive with acid resistant silane coupling agent will be actively applied for 20 second , then light cured for 20 seconds then the restoration will be placed
After cavity preparations, enamel margins will be etched for 30 seconds then rinsed and dried, then the Universal adhesive which contains acid resistant silane coupling agent will be actively applied for 20 seconds then air thinned for 5 seconds then cured for 20 seconds.Then the composite restoration will be placed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Retention (Success rate)
Time Frame: T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.
Alpha (A) Present Bravo (B) Partial loss but clinically acceptable Charlie (C)Clinically unacceptable partial loss or absent
T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Marginal adaptation
Time Frame: T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.

Alpha (A) Restoration adapts closely to the tooth structure; there is no visible crevice.

Bravo (B) There is a visible crevice, the explorer will penetrate, without dentin exposure.

Charlie(C)The explorer penetrates into a crevice in which dentin or the base is exposed.

T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.
Marginal discoloration
Time Frame: T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.

Alpha (A) No marginal discoloration. Bravo (B) Minor marginal discoloration without staining toward the pulp, only visible using a mirror and operating light.

Charlie(C) Deep discoloration with staining toward the pulp, visible at a speaking distance of 60 to 100 cm.

T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.
Secondary caries
Time Frame: T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.
Alpha (A) No active caries present Charlie(C) Active caries is present in contact with the restoration
T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2024

Primary Completion (Estimated)

April 30, 2026

Study Completion (Estimated)

April 30, 2026

Study Registration Dates

First Submitted

August 23, 2024

First Submitted That Met QC Criteria

August 23, 2024

First Posted (Actual)

August 26, 2024

Study Record Updates

Last Update Posted (Actual)

September 4, 2024

Last Update Submitted That Met QC Criteria

August 30, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CairoU ARS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Caries

Clinical Trials on universal adhesive with Acid resistant silane coupling agent

Subscribe